Three things to know:
1. An increase in medical research has aided the growth of medical tech companies, according to the report.
“Medical knowledge will double every 73 days by 2020 vs. every 3.5 [years] in 2010, and genomic sequencing costs have fallen 99.999 [percent] since 2003,” the analysts wrote, CNBC reports. “This has enabled a new frontier in precision medicine to further extend life expectancy, heralding a ‘techmanity’ [technology meets humanity] revolution.”
2. The analysts credit innovation in genomics, data and artificial intelligence, wearable technology, agricultural gene editing and surgical technology as factors that will drive the lifespan extension.
3. Companies that aim to delay human death will continue to increase in the next decade, with the market estimated to be worth $600 billion by 2025.
More articles on health IT:
Google AI Impact Challenge awards grants to 7 health initiatives
Amgen, Syapse partner to develop precision medicine solutions in oncology
How CHI’s virtually integrated care model seeks to transform nursing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
